Voyager Therapeutics: 3Q Earnings Snapshot

November 7, 2018

CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Wednesday reported a loss of $20.3 million in its third quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 63 cents.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.

The gene therapy company posted revenue of $2.1 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $3 million.

Voyager Therapeutics shares have declined 16 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.99, a climb of roughly 5 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR

Update hourly